Michael Malafronte Purchases 8,890 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) Director Michael Malafronte purchased 8,890 shares of Adtalem Global Education stock in a transaction dated Wednesday, March 11th. The shares were purchased at an average cost of $100.94 per share, for a total transaction of $897,356.60. Following the completion of the transaction, the director owned 25,395 shares of the company’s stock, valued at approximately $2,563,371.30. This represents a 53.86% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Adtalem Global Education Price Performance

Shares of CVSA stock opened at $105.18 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.68 and a quick ratio of 0.68. Adtalem Global Education Inc. has a 12-month low of $86.97 and a 12-month high of $156.26. The firm has a market capitalization of $3.63 billion, a PE ratio of 13.38, a PEG ratio of 0.88 and a beta of 0.72.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings data on Wednesday, January 28th. The company reported $2.43 EPS for the quarter. The business had revenue of $503.39 million for the quarter. Adtalem Global Education had a return on equity of 20.24% and a net margin of 13.41%.

Analyst Upgrades and Downgrades

CVSA has been the topic of a number of research analyst reports. Weiss Ratings initiated coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They set a “hold (c+)” rating on the stock. Zacks Research upgraded Adtalem Global Education from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, February 24th. Finally, Barrington Research restated an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a report on Monday, March 2nd. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $170.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.